Markoorsig

The vaccine delivery devices market experienced significant growth amidst the COVID-19 pandemic. Despite initial challenges such as limited production and supply chain disruptions due to government regulations, the market continued to expand as the demand for effective vaccines and a cure for the disease increased. The availability of novel vaccine delivery devices was crucial in meeting this demand, thereby driving market growth.

Government initiatives and widespread vaccination campaigns played a key role in accelerating the availability of vaccine delivery devices globally. For instance, the Pan American Health Organization (PAHO) called for a vaccination campaign to address the vaccination gap, including COVID-19 immunization in the United States. Daarbenewens, data from the World Health Organization (WHO) revealed that over 16 billion vaccine doses, valued at $141 miljard, were supplied in 2021, three times higher than previous years, primarily driven by COVID-19 vaccines. The development of these vaccines consequently led to an increased demand for vaccine delivery devices. Thus, the COVID-19 pandemic has had a significant impact on the market, and it is expected to continue driving growth in the forecast period.

Market players are also actively engaged in strategic activities like mergers, acquisitions, and product launches to enhance product availability. For example, Becton, Dickinson and Company introduced the BD Effivax, a next-generation glass pre-fillable syringe (PFS) in September 2022. This PFS sets new standards for performance in terms of processability, cosmetics, contamination, and integrity. Bowendien, in August 2021, the Drug Controller General of India (DCGI) approved the ZyCoV-D plasmid DNA vaccine for COVID-19, which is exclusively administered using the PharmaJet Tropis Needle-free Jet Injection System. The introduction of technologically advanced products is expected to drive market growth during the forecast period.

In summary, the growth of the vaccine delivery devices market is fueled by increasing immunization programs, investment in vaccine research, and the development of novel drug delivery technologies. However, the high cost of microneedles may pose a restraint on market growth during the analysis period.

Marksegmentasie

The market is segmented based on various factors, including product type, end user, en streek.

Segmentation by Product Type
Syringes
Jet Injectors
Other Product Types

Segmentation by End User
Hospitals
Clinics
Other End Users

Segmentation by Region
Noord-Amerika – Verenigde State, Kanada, and Mexico
Europa – Verenigde Koninkryk, Duitsland, Frankryk, Italië, Spanje, and Rest of Europe
Asia-Pacific – Sjina, Japan, Indië, South Korea, Australië, and Rest of Asia-Pacific
Latyns-Amerika – Brasilië, Argentinië, and Rest of Latin America
Midde-Ooste en Afrika – Suid-Afrika, GCC, and Rest of Middle East and Africa

The syringes segment held the largest market share in the vaccine delivery devices market, with a value of USD 3,703 miljoen in 2022. It is expected to continue its growth with a projected CAGR of 6.60% over the forecast period. Syringes are widely used in hospitals and clinics to administer vaccines and medication. They offer various benefits such as waste reduction, better storage, and time efficiency. The World Health Organization (WHO) also recommends the usage of auto-disable (AD) syringes for immunization programs due to their safety features. The demand for syringes in vaccine delivery is expected to increase, driving the growth of this segment.

The hospital segment accounted for the largest share in the vaccine delivery devices market among end users, with a value of USD 2,114 miljoen in 2022. It is expected to grow at a CAGR of 6.62% over the forecast period. Hospitals play a crucial role in immunization programs and have advanced facilities and healthcare professionals to handle vaccines. The increase in the number of hospitals, especially in developing countries, and government and private investments in healthcare infrastructure contribute to the growth of this segment.

North America dominated the vaccine delivery devices market, with a value of USD 1,994 miljoen in 2022. It is expected to maintain its major market share over the forecast period. The region’s growth can be attributed to investment in vaccine research and development, availability of funding opportunities, and technological innovations. The United States leads in vaccine R&D and has seen promising results from clinical trials. Daarbenewens, the presence of manufacturers, increased vaccination awareness, and initiatives by organizations like CDC and ACL to promote vaccine equity further contribute to the market growth in North America.

The United States is expected to have the highest market share globally in the vaccine delivery devices market. Factors such as rising demand for vaccines, advancements in delivery devices, well-established healthcare infrastructure, and government focus on immunization programs contribute to the market growth. Increased funding from government and international organizations also accelerates vaccine development in the country.

Overall, the syringes segment, hospital end users, and North America region are expected to drive the growth of the vaccine delivery devices market due to various factors such as safety, convenience, and increased investment in healthcare.

Mededingende landskap

The market for vaccine delivery devices is characterized by intense competition, with numerous companies operating on a global and regional scale. The competitive landscape comprises an examination of various international and local companies that possess substantial market shares and enjoy widespread recognition. Among the key players in the global market are Becton, Dickinson and Company, B. Braun Melsungen AG, Terumo Corporation, Gerresheimer AG, and PharmaJet Inc., among others.

Key companies profiled in this report include Becton, Dickinson and Company, B. Braun Melsungen AG, Terumo Corporation, Zhejiang Longde Pharmaceutical Co., Bpk, VAXXAS, Hindustan Syringes & Medical Devices Ltd, Gerresheimer AG, Carl-Zeiss-Stiftung (SCHOTT AG), Enesi Pharma, PharmaJet Inc., Mystic Pharmaceuticals Inc.

Recent Industry Developments

In December 2022, the Central Drugs Standard Control Organization (CDSCO) in India granted approval to Bharat Biotech International Limited (BBIL) for their nasal COVID-19 vaccine, with usage restricted to emergency situations for individuals aged 18 and above.

In January 2022, Pfizer and Acuitas Therapeutics entered into a partnership agreement to develop a lipid nanoparticle delivery system specifically designed for mRNA vaccines and therapeutics.

Key Questions Answered

What is the study period of this market?
The study of the Vaccine Delivery Devices Market spans from 2018 aan 2028.

What is the growth rate of the Vaccine Delivery Devices Market?
The Vaccine Delivery Devices Market is projected to grow at a compound annual growth rate (CAGR) van 6.89% over the next five years.

What is the size of the Vaccine Delivery Devices Market in 2018?
The Vaccine Delivery Devices Market was valued at 5108 million USD in 2018.

What is the size of the Vaccine Delivery Devices Market in 2028?
The Vaccine Delivery Devices Market is projected to reach a value of 7586 million USD in 2028.

Which region has the highest growth rate in the Vaccine Delivery Devices Market?
Asia-Pacific is experiencing the highest CAGR from 2018 aan 2028 in the Vaccine Delivery Devices Market.

Which region has the largest share in the Vaccine Delivery Devices Market?
North America holds the highest share in the Vaccine Delivery Devices Market in 2022.

Who are the key players in the Vaccine Delivery Devices Market?
The major companies operating in the Vaccine Delivery Devices Market are Terumo, B. Braun Melsungen AG, Becton, Dickinson and Company, Gerresheimer AG, and PharmaJet Inc.